SOLV

+ Watchlist + Portfolio

Solventum Corp.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $87.81
52-Week Range: $62.38 – $90.00
Market Cap: $15.08B
P/E (TTM): 10.83
EPS (TTM): 8.18
Dividend Yield: —

Advanced Metrics

Price/Book: 3.09
PEG Ratio: 1.22
Return on Equity: 33.96%
Return on Assets: 2.70%
Gross Margin: 54.78%
Operating Margin: 9.78%
Profit Margin: 17.26%
Current Ratio: 1.02
Debt/Equity: 1.10
Total Debt: $5.30B
Free Cash Flow: $489.00M
Revenue Growth: 2.20%
Earnings Growth: 3.90%
Enterprise Value: $19.84B

SOLV Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$8.13B	$8.20B	$8.25B	$8.32B
Cost of Revenue	$3.44B	$3.50B	$3.66B	$3.87B
Gross Profit	$4.70B	$4.69B	$4.59B	$4.45B
Research & Development	$767.00M	$758.00M	$775.00M	$739.00M
Selling, General & Admin	$2.23B	$2.30B	$2.78B	$3.08B
Operating Expenses	$3.00B	$3.06B	$3.56B	$3.82B
Operating Income	$1.69B	$1.64B	$1.04B	$632.00M
EBITDA	$2.27B	$2.23B	$1.53B	$2.55B
Pretax Income	$1.69B	$1.67B	$605.00M	$1.71B
Income Tax	$349.00M	$321.00M	$127.00M	$157.00M
Net Income	$1.34B	$1.35B	$479.00M	$1.56B
Diluted EPS	7.78	7.79	2.76	8.88
Diluted Shares	172.70M	172.71M	173.70M	175.30M

SOLV Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$61.00M	$194.00M	$762.00M	$878.00M
Receivables	$1.17B	$1.31B	$1.23B	$1.18B
Inventory	$873.00M	$857.00M	$965.00M	$1.07B
Current Assets	$2.23B	$2.52B	$3.25B	$3.86B
Total Assets	$13.59B	$13.94B	$14.46B	$14.29B
Current Liabilities	$1.31B	$1.73B	$2.70B	$3.14B
Long-Term Debt	—	$8.30B	$7.81B	$5.04B
Total Debt	—	$8.30B	$8.01B	$5.04B
Total Liabilities	$1.85B	$2.28B	$11.50B	$9.24B
Retained Earnings	—	$0.00	$242.00M	$1.80B
Shareholders' Equity	$11.74B	$11.67B	$2.96B	$5.05B
Working Capital	$920.00M	$791.00M	$546.00M	$723.00M
Net Debt	—	$7.70B	$7.25B	$4.16B

SOLV Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$1.68B	$1.92B	$1.19B	$369.00M
Capital Expenditure	-$251.00M	-$290.00M	-$380.00M	-$379.00M
Free Cash Flow	$1.43B	$1.63B	$805.00M	-$10.00M
Depreciation & Amortisation	$578.00M	$561.00M	$555.00M	$489.00M
Stock-Based Compensation	$37.00M	$39.00M	$112.00M	$161.00M
Investing Cash Flow	-$253.00M	-$230.00M	-$380.00M	$2.80B
Financing Cash Flow	-$1.46B	-$1.55B	-$240.00M	-$3.06B
Net Change in Cash	-$34.00M	$133.00M	$565.00M	$109.00M

SOLV Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$2.07B	$2.16B	$2.10B	$2.00B	$2.01B
Cost of Revenue	$956.00M	$986.00M	$961.00M	$971.00M	$911.00M
Gross Profit	$1.11B	$1.18B	$1.14B	$1.03B	$1.09B
Research & Development	$193.00M	$189.00M	$183.00M	$175.00M	$189.00M
Selling, General & Admin	$769.00M	$772.00M	$780.00M	$759.00M	$827.00M
Operating Expenses	$962.00M	$961.00M	$963.00M	$934.00M	$1.02B
Operating Income	$152.00M	$214.00M	$172.00M	$93.00M	$79.00M
EBITDA	$271.00M	$328.00M	$1.72B	$226.00M	$213.00M
Pretax Income	$38.00M	$103.00M	$1.51B	$58.00M	$16.00M
Income Tax	-$99.00M	$13.00M	$248.00M	-$5.00M	$3.00M
Net Income	$137.00M	$90.00M	$1.27B	$63.00M	$13.00M
Diluted EPS	0.78	0.51	7.22	0.36	0.07
Diluted Shares	174.80M	175.20M	175.40M	175.70M	175.50M

SOLV Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$534.00M	$492.00M	$1.64B	$878.00M	$561.00M
Receivables	$1.11B	$1.25B	$1.18B	$1.18B	$1.18B
Inventory	$866.00M	$962.00M	$1.05B	$1.07B	$1.09B
Current Assets	$3.05B	$3.21B	$4.41B	$3.86B	$3.58B
Total Assets	$14.53B	$15.07B	$13.97B	$14.29B	$14.10B
Current Liabilities	$2.57B	$2.62B	$2.94B	$3.14B	$3.35B
Long-Term Debt	$7.81B	$7.82B	$5.14B	$5.04B	$4.58B
Total Debt	$7.91B	$7.82B	$5.14B	$5.04B	$5.29B
Total Liabilities	$11.27B	$11.43B	$8.99B	$9.24B	$9.13B
Retained Earnings	$378.00M	$468.00M	$1.73B	$1.80B	$1.81B
Shareholders' Equity	$3.26B	$3.65B	$4.99B	$5.05B	$4.97B
Working Capital	$487.00M	$588.00M	$1.47B	$723.00M	$237.00M
Net Debt	$7.38B	$7.32B	$3.50B	$4.16B	$4.52B

SOLV Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	$29.00M	$169.00M	$76.00M	$95.00M	-$189.00M
Capital Expenditure	-$109.00M	-$110.00M	-$97.00M	-$63.00M	-$84.00M
Free Cash Flow	-$80.00M	$59.00M	-$21.00M	$32.00M	-$273.00M
Depreciation & Amortisation	$129.00M	$122.00M	$121.00M	$117.00M	$135.00M
Stock-Based Compensation	$49.00M	$34.00M	$41.00M	$37.00M	$51.00M
Investing Cash Flow	-$114.00M	-$110.00M	$3.77B	-$745.00M	-$77.00M
Financing Cash Flow	-$139.00M	-$110.00M	-$2.69B	-$115.00M	-$50.00M
Share Repurchases	$0.00	—	—	—	-$67.00M
Net Change in Cash	-$224.00M	-$51.00M	$1.15B	-$765.00M	-$315.00M

Market Snapshot

About

Solventum Corp. is a healthcare company focused on developing medical solutions and technologies. Spun off from 3M Company in 2024, Solventum specializes in healthcare products including medical and surgical supplies, health information systems, and dental products.